BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 22143672)

  • 1. Epigenetic regulation of miRNA genes in acute leukemia.
    Agirre X; Martínez-Climent JÁ; Odero MD; Prósper F
    Leukemia; 2012 Mar; 26(3):395-403. PubMed ID: 22143672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
    Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
    Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and human cancer.
    Nikitina EG; Urazova LN; Stegny VN
    Exp Oncol; 2012; 34(1):2-8. PubMed ID: 22453141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.
    Wang LQ; Liang R; Chim CS
    Expert Rev Mol Diagn; 2012 Sep; 12(7):755-65. PubMed ID: 23153241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of microRNA alterations in leukemias and lymphomas.
    Calin GA; Croce CM
    Methods Enzymol; 2007; 427():193-213. PubMed ID: 17720486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs in acute myeloid leukemia.
    Liao Q; Wang B; Li X; Jiang G
    Oncotarget; 2017 Jan; 8(2):3666-3682. PubMed ID: 27705921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in acute leukemia: from biological players to clinical contributors.
    Schotte D; Pieters R; Den Boer ML
    Leukemia; 2012 Jan; 26(1):1-12. PubMed ID: 21701489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of microRNAs in hematological malignancies.
    Fatica A; Bozzoni I
    Expert Rev Hematol; 2009 Aug; 2(4):415-23. PubMed ID: 21082946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic mechanisms in AML - a target for therapy.
    Oki Y; Issa JP
    Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
    Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia.
    Roman-Gomez J; Agirre X; Jiménez-Velasco A; Arqueros V; Vilas-Zornoza A; Rodriguez-Otero P; Martin-Subero I; Garate L; Cordeu L; San José-Eneriz E; Martin V; Castillejo JA; Bandrés E; Calasanz MJ; Siebert R; Heiniger A; Torres A; Prosper F
    J Clin Oncol; 2009 Mar; 27(8):1316-22. PubMed ID: 19164206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
    Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
    Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics and microRNAs.
    Chuang JC; Jones PA
    Pediatr Res; 2007 May; 61(5 Pt 2):24R-29R. PubMed ID: 17413852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies.
    Andersson A; Edén P; Olofsson T; Fioretos T
    BMC Med Genomics; 2010 Mar; 3():6. PubMed ID: 20211010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics and microRNAs.
    Saetrom P; Snøve O; Rossi JJ
    Pediatr Res; 2007 May; 61(5 Pt 2):17R-23R. PubMed ID: 17413846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research advances on epigenetic regulation in leukemogenesis: microRNA and leukemia].
    Yang Y; Wang LL; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):520-4. PubMed ID: 20416202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs, epigenetics and disease.
    Silahtaroglu A; Stenvang J
    Essays Biochem; 2010 Sep; 48(1):165-85. PubMed ID: 20822493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation.
    Schaar DG; Medina DJ; Moore DF; Strair RK; Ting Y
    Exp Hematol; 2009 Feb; 37(2):245-55. PubMed ID: 19135902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization.
    Neaga A; Bagacean C; Tempescul A; Jimbu L; Mesaros O; Blag C; Tomuleasa C; Bocsan C; Gaman M; Zdrenghea M
    Front Immunol; 2020; 11():582915. PubMed ID: 33519805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.